In the present study, the increased tumor heterogeneity measured by texture analysis represents not only true clonal heterogeneity, which is a well-known cause of therapeutic resistance, but also overall features of the tumoral microenvironment determined by HER2 overexpression, including cell proliferation, angiogenesis, and necrosis. The gene discussed is ERBB2; the disease is neoplasm.